Can We Reliably Identify the Pathological Outcomes of Neoadjuvant Chemotherapy in Patients with Breast Cancer? Development and Validation of a Logistic Regression Nomogram Based on Preoperative Factors

BACKGROUND: Pathological responses of neoadjuvant chemotherapy (NCT) are associated with survival outcomes in patients with breast cancer. Previous studies constructed models using out-of-date variables to predict pathological outcomes, and lacked external validation, making them unsuitable to guide...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Jian, Xiao, Linhai, Pu, Shengyu, Liu, Yang, He, Jianjun, Wang, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Breast Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043913/
https://www.ncbi.nlm.nih.gov/pubmed/33095360
http://dx.doi.org/10.1245/s10434-020-09214-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043913/
https://www.ncbi.nlm.nih.gov/pubmed/33095360
http://dx.doi.org/10.1245/s10434-020-09214-x

Ejemplares similares